Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Computational Drug Design

Gerhard Ecker
Trends in natural products research
Conference, Talk or oral contribution
24.7.2013 - 24.7.2013

Integrated approaches - from docking poses to prediction of side effects

Gerhard Ecker
9th Joint Meeting on Medicinal Chemistry
Conference, Talk or oral contribution
1.7.2013 - 1.7.2013

RICT 2014 - Rencontres Internationales de Chimie Therapeutique

Gerhard Ecker
RICT 2014 - Rencontres Internationales de Chimie Therapeutique
Conference, Organisation of ...
1.7.2013 - 6.7.2014

Exploiting open data - a new era in pharmacoinformatics

Gerhard Ecker
9th European workshop in Drug Design
Seminar/Workshop, Talk or oral contribution
22.5.2013 - 22.5.2013

Open PHACTS - a novel platform for integrated data-driven drug discovery

Gerhard Ecker
Drug Discovery Innovations
Conference, Talk or oral contribution
20.3.2013 - 20.3.2013